Sodium valproate in pregnancy: what are the risks and should we use a shared decision-making approac...
Sodium valproate in pregnancy: what are the risks and should we use a shared decision-making approach?
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Despite significant teratogenic risks, sodium valproate is still widely prescribed in many countries to women of childbearing age, as a mood stabiliser in bipolar disorder and also in epilepsy. The UK has recently banned valproate use in women who are not in a pregnancy prevention programme. Whilst this ruling reflects prevailing clinical practice,...
Alternative Titles
Full title
Sodium valproate in pregnancy: what are the risks and should we use a shared decision-making approach?
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_0628a5f9c3f54e35976ae90c51b82aad
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0628a5f9c3f54e35976ae90c51b82aad
Other Identifiers
ISSN
1471-2393
E-ISSN
1471-2393
DOI
10.1186/s12884-018-1842-x
